[1]
Srivastava, S., Agarwal, S., Gulati, Y., Singh, A.K. and Aggarwal, P. 2025. Determining the role of SGLT2 inhibitors (dapagliflozin) on progression of proteinuria among non-diabetic adult patients with chronic kidney disease: a randomized controlled trial. International Journal of Advances in Medicine. 12, 6 (Oct. 2025), 553–557. DOI:https://doi.org/10.18203/2349-3933.ijam20253347.